Italian Pharma Company Selects Emerson to Enable Digital Transformation
September 12 2018 - 9:00AM
Business Wire
Multisite automation investment to help FIS
improve efficiency, quality and compliance of manufacturing
operations
FIS – Fabbrica Italiana Sintetici, a leading active
pharmaceutical ingredients manufacturer, has selected Emerson
(NYSE: EMR) to digitize operations and work processes at three
manufacturing sites in Italy. With the $20 million (€16.1 million)
contracts, Emerson will provide automation technology to help
create a fully electronic manufacturing environment for increased
efficiencies, quality and regulatory compliance.
“It is vital that FIS develops the right relationship to help it
expand operations in a measured and prudent manner,” said Franco
Moro, general manager of FIS. “Working with Emerson provides FIS
with a trusted partner as we digitize work processes and invest in
automation to improve production and efficiency.”
As part of its growth strategy, FIS constructed a new $123
million (€100 million) unit at its Termoli site, doubling capacity
to produce active pharmaceutical ingredients. Emerson will
implement its Syncade™ manufacturing execution system at the
Termoli site, as well as the Montecchio facility, providing
automated workflows and paperless procedures and record-keeping.
Paperless manufacturing improves production efficiency and offers
widespread benefits in compliance, product quality, inventory and
document control, which are critical in the highly regulated
pharmaceutical industry.
The two leading companies have partnered before; Emerson
provided its DeltaV™ distributed control system to monitor and
control manufacturing at the Termoli site in 2017. As part of this
latest agreement, Emerson will expand the automation system to
incorporate additional measurement and control instrumentation. By
standardizing on DeltaV across its Termoli, Montecchio and Lonigo
sites, FIS aims to improve efficiency and ensure consistent
operations.
“This project reinforces Emerson’s strong relationship with FIS,
and, as a trusted advisor, we will continue to support its business
objectives on a long-term basis,” said Mike Train, executive
president of Emerson Automation Solutions. “Our expertise will help
FIS further automate work processes and boost profitability across
these three sites as part of a companywide digital transformation
strategy.”
The contracts are part of a 10-year strategic framework
agreement signed with Emerson for the supply of its DeltaV and
Syncade systems, measurement instrumentation and control valves, as
well as a 10-year service agreement that covers the control systems
at all three sites plus the new MES systems at Termoli and
Montecchio.
For more information, visit Emerson.com/DeltaV and
Emerson.com/Syncade.
About Emerson
Emerson (NYSE: EMR), headquartered in St. Louis, Missouri (USA),
is a global technology and engineering company providing innovative
solutions for customers in industrial, commercial, and residential
markets. Our Emerson Automation Solutions business helps process,
hybrid, and discrete manufacturers maximize production, protect
personnel and the environment while optimizing their energy and
operating costs. Our Emerson Commercial & Residential Solutions
business helps ensure human comfort and health, protect food
quality and safety, advance energy efficiency, and create
sustainable infrastructure. For more information visit
Emerson.com.
Media:
- Inquiries:
AutomationSolutionsPR@Emerson.com
- Emerson Automation Solutions Global
Media Contacts
Additional resources:
- Join the Emerson Automation Solutions
Community
- Connect with Emerson Automation
Solutions viaTwitter Facebook LinkedIn Google+ YouTube
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180912005136/en/
For EmersonDenise Clarke,
512-587-5879denise.clarke@fleishman.com
Emerson Electric (NYSE:EMR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emerson Electric (NYSE:EMR)
Historical Stock Chart
From Apr 2023 to Apr 2024